Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pexastimogene devacirepvec (1 trial)
volociximab (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Melanoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Vaccinia (Phase 2)
Trials (2 total)
Trial APIs (2 total)